Dodecyl 2-methylacrylate | CAS:142-90-5

We serve Dodecyl 2-methylacrylate CAS:142-90-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Dodecyl 2-methylacrylate

Chemical Name:Dodecyl 2-methylacrylate
CAS.NO:142-90-5
Synonyms:Dodecyl 2-methylacrylate
Lauryl Methacrylate
dodecyl methacylate
Dodecylmethacrylat
Methacrylic Acid Dodecyl Ester
Molecular Formula:C16H30O2
Molecular Weight:254.40800
 
Physical and Chemical Properties:
Density:0.873
Melting point:−7ºC
Boiling point:142ºC
Flash point:>230°F
Index of Refraction:1.445
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like Dodecyl 2-methylacrylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Dodecylmethacrylat physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,dodecyl methacylate Use and application,Lauryl Methacrylate technical grade,usp/ep/jp grade.


Related News: Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.Uridine manufacturer The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.L-Threonine supplier We purchase the raw materials from raw material or chemical product manufacturers both in Japan and internationally.4-Bromo-2,3-difluorobenzaldehyde vendor It also said it would bar South Koreans from visiting China as tourists.Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.